- Retraction Note
- Open Access
- Published:
Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2
Journal of Experimental & Clinical Cancer Research volume 42, Article number: 54 (2023)
The Original Article was published on 22 September 2021
Retraction Note: J Exp Clin Cancer Res 40, 299 (2021)
https://doi.org/10.1186/s13046-021-02090-7
The Editor in Chief has retracted this article. After publication, concerns were raised about an apparent partial overlap between the leftmost SNU-449 migration panel in Fig. 2C and the top LNCAROD+2-DG panel in Fig. 4G. The authors were unable to provide a satisfactory set of raw data on request. Additionally, the issues regarding the provenance of cell lines were not completely resolved in the published version of the article. The editor, therefore, has lost confidence in the integrity of the findings of this article. The authors have not explicitly stated that they agree to this retraction.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Jia, G., Wang, Y., Lin, C. et al. Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2. J Exp Clin Cancer Res 42, 54 (2023). https://doi.org/10.1186/s13046-023-02626-z
Published:
DOI: https://doi.org/10.1186/s13046-023-02626-z